(2017). Merck Sharp & Dohme Corp. v. Hospira, Inc.United States Court of Appeals of the Federal Circuit, 2017No. 2017-1115, 2017 WL 4819091. Biotechnology Law Report, 36(6), 315. https://doi.org/10.1089/blr.2017.29046.mer
Chicago Style (17th ed.) Citation"Merck Sharp & Dohme Corp. V. Hospira, Inc.United States Court of Appeals of the Federal Circuit, 2017No. 2017-1115, 2017 WL 4819091." Biotechnology Law Report 36, no. 6 (2017): 315. https://doi.org/10.1089/blr.2017.29046.mer.
MLA (9th ed.) Citation"Merck Sharp & Dohme Corp. V. Hospira, Inc.United States Court of Appeals of the Federal Circuit, 2017No. 2017-1115, 2017 WL 4819091." Biotechnology Law Report, vol. 36, no. 6, 2017, p. 315, https://doi.org/10.1089/blr.2017.29046.mer.
Warning: These citations may not always be 100% accurate.
